Metropolitan Life Insurance Company (MetLife)’s Spectranetics Corp SPNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-30,681
| Closed | -$1.18M | – | 2592 |
|
|
2017
Q2 | $1.18M | Hold |
30,681
| – | – | 0.01% | 1151 |
|
|
2017
Q1 | $894K | Sell |
30,681
-1,117
| -4% | -$29.8K | 0.01% | 1288 |
|
|
2016
Q4 | $779K | Buy |
31,798
+38
| +0.1% | +$894 | 0.01% | 1442 |
|
|
2016
Q3 | $797K | Hold |
31,760
| – | – | 0.01% | 1413 |
|
|
2016
Q2 | $594K | Hold |
31,760
| – | – | ﹤0.01% | 1578 |
|
|
2016
Q1 | $461K | Hold |
31,760
| – | – | ﹤0.01% | 1625 |
|
|
2015
Q4 | $478K | Hold |
31,760
| – | – | ﹤0.01% | 1650 |
|
|
2015
Q3 | $374K | Hold |
31,760
| – | – | ﹤0.01% | 1828 |
|
|
2015
Q2 | $731K | Sell |
31,760
-1,548
| -5% | -$43.2K | 0.01% | 1502 |
|
|
2015
Q1 | $1.16M | Hold |
33,308
| – | – | 0.01% | 1130 |
|
|
2014
Q4 | $1.15M | Sell |
33,308
-773
| -2% | -$24.1K | 0.01% | 1244 |
|
|
2014
Q3 | $906K | Hold |
34,081
| – | – | 0.01% | 1344 |
|
|
2014
Q2 | $780K | Hold |
34,081
| – | – | 0.01% | 1524 |
|
|
2014
Q1 | $1.03M | Hold |
34,081
| – | – | 0.01% | 1327 |
|
|
2013
Q4 | $852K | Hold |
34,081
| – | – | 0.01% | 1445 |
|
|
2013
Q3 | $572K | Hold |
34,081
| – | – | ﹤0.01% | 1673 |
|
|
2013
Q2 | $637K | Buy |
+34,081
| New | +$645K | 0.01% | 1536 |
|
Metropolitan Life Insurance Company (MetLife)'s SPNC Position: Q3 2017 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Spectranetics Corp (SPNC) in Q3 2017, closing a stake of 30,681 shares — an estimated $1.18M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SPNC in Q2 2013 and held it in 17 quarters. The position peaked at $1.18M in Q2 2017. 0 funds tracked by Wall St. Rank hold SPNC as of Q3 2017.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Spectranetics Corp position as of Q3 2017 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 30,681 Spectranetics Corp shares in Q3 2017, an estimated $1.18M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Spectranetics Corp in Q2 2013 and held it in 17 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Spectranetics Corp position peaked at $1.18M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Spectranetics Corp as of Q3 2017.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2017, filed 14 Nov 2017.